FAP and cancer: Due to the preferential expression of FAP in CAFs and their scarcity in normal tissues, radiolabeled FAP inhibitors (FAPIs) have emerged as valuable tools for cancer theranostics, particularly in tumors characterized by extensive fibrotic stroma.